File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Nasopharynx

TitleNasopharynx
Authors
Lee, AWMNg, WTLe, QTChan, ATCChan, JYWSze, HCK
Editors
Editor(s):O’Sullivan, B
KeywordsNasopharyngeal cancer
Staging
Prognostic factors
Radiotherapy
Chemotherapy
Surgery
Issue Date2015
PublisherJohn Wiley & Sons, Ltd.
Citation
Nasopharynx. In O'Sullivan, B et al. (Eds.), UICC Manual of Clinical Oncology (9th ed.), p. 512-523. Chichester, UK: John Wiley & Sons, Ltd., 2015 How to Cite?
DOI: http://dx.doi.org/10.1002/9781119013143.ch42
AbstractNasopharyngeal carcinoma (NPC) is one of the most interesting cancers with a distinctly skewed distribution. The aetiology is multifactorial (genetic predisposition, Epstein‐Barr virus infection and environmental carcinogens). The most significant prognostic factors include TNM staging, tumour volume, EBV‐DNA copies, age and gender. Radiotherapy is the primary treatment modality, with the intensity‐modulated radiotherapy technique recommended. Addition of cisplatin‐based concurrent ± adjuvant chemotherapy is recommended for treatment of locoregionally advanced tumours. The current consensus and controversies in treatment strategy for different stages and areas for research will be presented.
Persistent Identifierhttp://hdl.handle.net/10722/220044
ISBN
9781444332445

 

DC FieldValueLanguage
dc.contributor.authorLee, AWM-
dc.contributor.authorNg, WT-
dc.contributor.authorLe, QT-
dc.contributor.authorChan, ATC-
dc.contributor.authorChan, JYW-
dc.contributor.authorSze, HCK-
dc.contributor.editorO’Sullivan, B-
dc.date.accessioned2015-10-16T06:16:43Z-
dc.date.available2015-10-16T06:16:43Z-
dc.date.issued2015-
dc.identifier.citationNasopharynx. In O'Sullivan, B et al. (Eds.), UICC Manual of Clinical Oncology (9th ed.), p. 512-523. Chichester, UK: John Wiley & Sons, Ltd., 2015-
dc.identifier.isbn9781444332445-
dc.identifier.urihttp://hdl.handle.net/10722/220044-
dc.description.abstractNasopharyngeal carcinoma (NPC) is one of the most interesting cancers with a distinctly skewed distribution. The aetiology is multifactorial (genetic predisposition, Epstein‐Barr virus infection and environmental carcinogens). The most significant prognostic factors include TNM staging, tumour volume, EBV‐DNA copies, age and gender. Radiotherapy is the primary treatment modality, with the intensity‐modulated radiotherapy technique recommended. Addition of cisplatin‐based concurrent ± adjuvant chemotherapy is recommended for treatment of locoregionally advanced tumours. The current consensus and controversies in treatment strategy for different stages and areas for research will be presented.-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Ltd.-
dc.relation.ispartofUICC Manual of Clinical Oncology (9th ed.)-
dc.subjectNasopharyngeal cancer-
dc.subjectStaging-
dc.subjectPrognostic factors-
dc.subjectRadiotherapy-
dc.subjectChemotherapy-
dc.subjectSurgery-
dc.titleNasopharynx-
dc.typeBook_Chapter-
dc.identifier.emailLee, AWM: awmlee@hkucc.hku.hk-
dc.identifier.emailNg, WT: ngwt1@hkucc.hku.hk-
dc.identifier.emailChan, JYW: jywchan1@hku.hk-
dc.identifier.emailSze, HCK: henrysze@graduate.hku.hk-
dc.identifier.authorityLee, AWM=rp02056-
dc.identifier.authorityNg, WT=rp02671-
dc.identifier.authorityChan, JYW=rp01314-
dc.identifier.authoritySze, HCK=rp01697-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/9781119013143.ch42-
dc.identifier.hkuros265591-
dc.identifier.hkuros233991-
dc.identifier.spage512-
dc.identifier.epage523-
dc.publisher.placeChichester, UK-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats